Advertisement

Topics

Big 5 Sporting Goods Corporation to Report Fiscal 2015 Second Quarter Results on July 28, 2015

20:00 EDT 20 Jul 2015 | Globe Newswire

EL SEGUNDO, Calif., July 21, 2015 (GLOBE NEWSWIRE) -- Big 5 Sporting Goods Corporation (NASDAQ:BGFV), a leading sporting goods retailer, will announce second quarter fiscal 2015 financial results on Tuesday, July 28, 2015, after the market close. The Company also will hold a conference call and audio webcast to discuss these results and provide additional comments and details.

The conference call and audio webcast is scheduled to begin at 2:00 p.m. Pacific (5:00 p.m. EDT) on July 28, 2015. The webcast also will be broadcast live over the Internet at www.big5sportinggoods.com. The webcast will be archived and accessible on the same website for 30 days following the call. Visitors to the website should select the "Investor Relations" link to access the webcast.

About Big 5 Sporting Goods Corporation

Big 5 is a leading sporting goods retailer in the western United States, operating 439 stores under the "Big 5 Sporting Goods" name as of the fiscal quarter ended June 28, 2015. Big 5 provides a full-line product offering in a traditional sporting goods store format that averages 11,000 square feet. Big 5's product mix includes athletic shoes, apparel and accessories, as well as a broad selection of outdoor and athletic equipment for team sports, fitness, camping, hunting, fishing, tennis, golf, winter and summer recreation and roller sports.

CONTACT: Big 5 Sporting Goods Corporation
         Barry Emerson
         Sr. Vice President and Chief Financial Officer
         (310) 536-0611
         
         ICR, Inc.
         John Mills
         Partner
         (310) 954-1105
NEXT ARTICLE

More From BioPortfolio on "Big 5 Sporting Goods Corporation to Report Fiscal 2015 Second Quarter Results on July 28, 2015"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...